Table 1 Baseline of clinical and biochemical characteristics of 14 CAD patients

Age (years)

51.8 ± 10.9

54 ± 13.5

51.9 ± 10.8

0.958

Male, n (%)

1 (25)

3 (100)

7 (100)

0.008*

Race- Malay, n (%)

4 (100)

3 (100)

7 (100)

–

Hypertension, n (%)

2 (50)

3 (100)

6 (86)

0.227

Hyperlipidemia, n (%)

2 (50)

2 (67)

6 (86)

0.442

Diabetes mellitus, n (%)

4 (100)

2 (67)

4 (57)

0.311

Smoking, n (%)

1 (25)

0 (0)

2 (29)

0.171

Atorvastatin, n (%)

4 (100)

3 (100)

6 (86)

0.584

Ezetimibe, n (%)

0 (0)

1 (33)

4 (57)

0.163

Ejection fraction (EF) (%)

51.98 ± 18.94

63.63 ± 14.60

47.50 ± 19.87

0.496

Total cholesterol (mg/dL)

3.66 ± 1.30

5.24 ± 0.66

5.40 ± 1.14

0.098

Triglycerides (mg/dL)

0.98 (0.31)

1.17 (0.00)

1.46 (1.19)

0.060

LDL cholesterol (mg/dL)

2.16 ± 1.04

3.09 ± 0.80

3.41 ± 0.87

0.172

HDL cholesterol (mg/dL)

1.06 ± 0.54

1.05 ± 0.13

1.28 ± 0.14

0.552

Fasting blood glucose (mmol/L)

7.90 ± 2.51

7.00 ± 3.08

7.26 ± 1.84

0.859

Serum creatinine (μmol/L)

76.50 ± 16.18

109.00 ± 29.61

95.57 ± 12.67

0.092